Letter Regarding "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib".

J Thorac Oncol

Department of Internal Medicine, Kyoto Min-Iren Asukai Hospital, Kyoto, Japan; Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan; Section of Clinical Epidemiology, Department of Community Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2024.06.009DOI Listing

Publication Analysis

Top Keywords

letter "clinical
4
"clinical utility
4
utility circulating
4
circulating tumor
4
tumor dna
4
dna patients
4
patients advanced
4
advanced krasg12c-mutated
4
krasg12c-mutated nsclc
4
nsclc treated
4

Similar Publications

HLA-C*03:657 differs from HLA-C*03:04:01:02 by one nucleotide substitution in codon 82 in exon 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!